ANI PHARMACEUTICALS, INC Increase (Decrease) in Income Taxes
ANI PHARMACEUTICALS, INC (ANIP) reported Increase (Decrease) in Income Taxes of $12.32 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInIncomeTaxes · last filed 2026-08-07
- ANI PHARMACEUTICALS, INC increase (decrease) in income taxes for the quarter ending 2026-06-30 was -$1.77M.
- ANI PHARMACEUTICALS, INC increase (decrease) in income taxes for the quarter ending 2026-03-31 was $14.09M, a 89.37% increase year-over-year.
- ANI PHARMACEUTICALS, INC increase (decrease) in income taxes for the quarter ending 2025-12-31 was $472.00K, a 96.33% decline year-over-year.
- ANI PHARMACEUTICALS, INC increase (decrease) in income taxes for the quarter ending 2025-09-30 was -$12.55M.
- ANI PHARMACEUTICALS, INC increase (decrease) in income taxes for fiscal 2025 was -$15.53M.
- ANI PHARMACEUTICALS, INC increase (decrease) in income taxes for fiscal 2024 was -$1.42M, a 111.80% decline from fiscal 2023.
- ANI PHARMACEUTICALS, INC increase (decrease) in income taxes for fiscal 2023 was $11.99M.
- ANI PHARMACEUTICALS, INC increase (decrease) in income taxes for fiscal 2022 was -$160.00K.
| Period end | Increase (Decrease) in Income Taxes 3 month | Increase (Decrease) in Income Taxes 6 month | Increase (Decrease) in Income Taxes 9 month | Increase (Decrease) in Income Taxes 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $12.32M 10-Q · filed 2026-08-07 | $12.79M derived: sum of 3 quarters · filed 2026-08-07 | $241.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $14.09M 10-Q · filed 2026-05-08 | $14.56M derived: sum of 2 quarters · filed 2026-05-08 | $2.01M derived: sum of 3 quarters · filed 2026-05-08 | -$8.88M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $472.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$12.08M derived: sum of 2 quarters · filed 2026-02-27 | -$22.97M derived: sum of 3 quarters · filed 2026-08-07 | -$15.53M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$12.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$23.44M derived: sum of 2 quarters · filed 2026-08-07 | -$16.00M 10-Q · filed 2025-11-07 | -$3.15M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$10.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$3.46M 10-Q · filed 2026-08-07 | $9.40M derived: sum of 3 quarters · filed 2026-08-07 | $6.16M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $7.44M 10-Q · filed 2026-05-08 | $20.29M derived: sum of 2 quarters · filed 2026-05-08 | $17.05M derived: sum of 3 quarters · filed 2026-05-08 | $2.79M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $12.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $9.62M derived: sum of 2 quarters · filed 2026-02-27 | -$4.65M derived: sum of 3 quarters · filed 2026-02-27 | -$1.42M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$3.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$17.51M derived: sum of 2 quarters · filed 2025-11-07 | -$14.27M 10-Q · filed 2025-11-07 | -$6.70M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$14.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$11.03M 10-Q · filed 2025-08-08 | -$3.47M derived: sum of 3 quarters · filed 2026-02-27 | $1.22M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $3.24M 10-Q · filed 2025-05-09 | $10.80M derived: sum of 2 quarters · filed 2026-02-27 | $15.49M derived: sum of 3 quarters · filed 2026-02-27 | $15.14M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $7.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $12.25M derived: sum of 2 quarters · filed 2026-02-27 | $11.90M derived: sum of 3 quarters · filed 2026-02-27 | $11.99M 10-K · filed 2026-02-27 |
| 2023-09-30 | $4.69M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $4.33M derived: sum of 2 quarters · filed 2024-11-08 | $4.43M 10-Q · filed 2024-11-08 | $4.38M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | -$353.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$261.00K 10-Q · filed 2024-08-06 | -$310.00K derived: sum of 3 quarters · filed 2025-02-28 | -$2.08M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $92.00K 10-Q · filed 2024-05-10 | $43.00K derived: sum of 2 quarters · filed 2025-02-28 | -$1.72M derived: sum of 3 quarters · filed 2025-02-28 | -$1.75M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | -$49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$1.81M derived: sum of 2 quarters · filed 2025-02-28 | -$1.84M derived: sum of 3 quarters · filed 2025-02-28 | -$160.00K 10-K · filed 2025-02-28 |
| 2022-09-30 | -$1.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$1.80M derived: sum of 2 quarters · filed 2023-11-08 | -$111.00K 10-Q · filed 2023-11-08 | -$748.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$31.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $1.65M 10-Q · filed 2023-08-09 | $1.02M derived: sum of 3 quarters · filed 2024-02-29 | $362.00K derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $1.69M 10-Q · filed 2023-05-08 | $1.05M derived: sum of 2 quarters · filed 2024-02-29 | $393.00K derived: sum of 3 quarters · filed 2024-02-29 | -$5.64M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$637.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$1.29M derived: sum of 2 quarters · filed 2024-02-29 | -$7.33M derived: sum of 3 quarters · filed 2024-02-29 | -$7.57M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$655.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$6.69M derived: sum of 2 quarters · filed 2022-11-09 | -$6.94M 10-Q · filed 2022-11-09 | -$1.41M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-06-30 | -$6.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$6.28M 10-Q · filed 2022-08-08 | -$754.00K derived: sum of 3 quarters · filed 2023-03-09 | -$10.66M derived: sum of 4 quarters · filed 2023-03-09 |
| 2021-03-31 | -$247.00K 10-Q · filed 2022-05-10 | $5.28M derived: sum of 2 quarters · filed 2023-03-09 | -$4.63M derived: sum of 3 quarters · filed 2023-03-09 | -$11.56M derived: sum of 4 quarters · filed 2023-03-09 |
| 2020-12-31 | $5.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | -$4.38M derived: sum of 2 quarters · filed 2023-03-09 | -$11.32M derived: sum of 3 quarters · filed 2023-03-09 | $4.98M 10-K · filed 2023-03-09 |
| 2020-09-30 | -$9.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-01 | -$16.84M derived: sum of 2 quarters · filed 2021-11-01 | -$545.00K 10-Q · filed 2021-11-01 | -$807.00K derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-06-30 | -$6.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $9.36M 10-Q · filed 2021-08-06 | $9.10M derived: sum of 3 quarters · filed 2022-03-15 | $11.73M derived: sum of 4 quarters · filed 2022-03-15 |
| 2020-03-31 | $16.30M 10-Q · filed 2021-05-07 | $16.04M derived: sum of 2 quarters · filed 2022-03-15 | $18.66M derived: sum of 3 quarters · filed 2022-03-15 | $11.77M derived: sum of 4 quarters · filed 2022-03-15 |
| 2019-12-31 | -$262.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $2.37M derived: sum of 2 quarters · filed 2022-03-15 | -$4.53M derived: sum of 3 quarters · filed 2022-03-15 | -$6.10M 10-K · filed 2022-03-15 |
| 2019-09-30 | $2.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$4.27M derived: sum of 2 quarters · filed 2020-11-05 | -$5.84M 10-Q · filed 2020-11-05 | -$1.13M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-06-30 | -$6.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$8.46M 10-Q · filed 2020-08-06 | -$3.76M derived: sum of 3 quarters · filed 2021-03-11 | -$1.71M derived: sum of 4 quarters · filed 2021-03-11 |
| 2019-03-31 | -$1.57M 10-Q · filed 2020-05-07 | $3.13M derived: sum of 2 quarters · filed 2021-03-11 | $5.19M derived: sum of 3 quarters · filed 2021-03-11 | $3.52M derived: sum of 4 quarters · filed 2021-03-11 |
| 2018-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $6.76M derived: sum of 2 quarters · filed 2021-03-11 | $5.08M derived: sum of 3 quarters · filed 2021-03-11 | $6.18M 10-K · filed 2021-03-11 |
| 2018-09-30 | $2.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $380.00K derived: sum of 2 quarters · filed 2019-11-06 | $1.48M 10-Q · filed 2019-11-06 | $2.37M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | -$572.00K 10-Q · filed 2019-08-07 | $318.00K derived: sum of 3 quarters · filed 2020-02-27 | $2.26M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $1.10M 10-Q · filed 2019-05-09 | $1.99M derived: sum of 2 quarters · filed 2020-02-27 | $3.93M derived: sum of 3 quarters · filed 2020-02-27 | -$3.72M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $890.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $2.83M derived: sum of 2 quarters · filed 2020-02-27 | -$4.82M derived: sum of 3 quarters · filed 2020-02-27 | -$3.56M 10-K · filed 2020-02-27 |
| 2017-09-30 | $1.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$5.71M derived: sum of 2 quarters · filed 2018-11-06 | -$4.45M 10-Q · filed 2018-11-06 | -$1.12M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | -$7.65M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$6.39M 10-Q · filed 2018-08-07 | -$3.06M derived: sum of 3 quarters · filed 2019-02-27 | -$3.84M derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $1.26M 10-Q · filed 2018-05-08 | $4.58M derived: sum of 2 quarters · filed 2019-02-27 | $3.81M derived: sum of 3 quarters · filed 2019-02-27 | $4.81M derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $3.33M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $2.55M derived: sum of 2 quarters · filed 2019-02-27 | $3.55M derived: sum of 3 quarters · filed 2019-02-27 | $3.52M 10-K · filed 2019-02-27 |
| 2016-09-30 | -$779.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $221.00K derived: sum of 2 quarters · filed 2017-11-02 | $198.00K 10-Q · filed 2017-11-02 | $43.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $977.00K 10-Q · filed 2017-08-03 | $822.00K derived: sum of 3 quarters · filed 2018-02-27 | $872.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | -$23.00K 10-Q · filed 2017-05-04 | -$178.00K derived: sum of 2 quarters · filed 2018-02-27 | -$128.00K derived: sum of 3 quarters · filed 2018-02-27 | -$1.63M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$105.00K derived: sum of 2 quarters · filed 2018-02-27 | -$1.61M derived: sum of 3 quarters · filed 2018-02-27 | -$5.38M 10-K · filed 2018-02-27 |
| 2015-09-30 | $50.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$1.45M derived: sum of 2 quarters · filed 2016-11-03 | -$5.22M 10-Q · filed 2016-11-03 | -$2.12M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-06-30 | -$1.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$5.28M 10-Q · filed 2016-08-04 | -$2.17M derived: sum of 3 quarters · filed 2017-03-02 | -$1.04M derived: sum of 4 quarters · filed 2017-03-02 |
| 2015-03-31 | -$3.77M 10-Q · filed 2016-05-05 | -$663.00K derived: sum of 2 quarters · filed 2017-03-02 | $458.00K derived: sum of 3 quarters · filed 2017-03-02 | |
| 2014-12-31 | $3.11M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $4.23M derived: sum of 2 quarters · filed 2017-03-02 | $4.23M 10-K · filed 2017-03-02 | |
| 2014-09-30 | $1.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $1.12M 10-Q · filed 2015-11-03 | ||
| 2014-06-30 | $3.00K 10-Q · filed 2015-08-04 | |||
| 2013-12-31 | $20.00K 10-K · filed 2016-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |